Published ahead of print on March 27, 2003, doi:10.1164/rccm.200205-468OC
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 1711-1716, (2003)
© 2003 American Thoracic Society
Role of Neuregulin-1ß in the Developing Lung
Christiane E. L. Dammann,
Heber C. Nielsen and
Kermit L. Carraway, III
Department of Pediatrics, Division of Newborn Medicine, Tufts University and Floating Hospital for Children; Department of Cell Biology, Harvard Medical School; and Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Correspondence and requests for reprints should be addressed to Christiane E. L. Dammann, M.D., Department of Pediatrics, Division of Newborn Medicine, Floating Hospital for Children at Tufts-New England Medical Center, 750 Washington Street, Boston, MA. E-mail: cdammann{at}tufts-nemc.org
Neuregulins play a critical role in the developing heart, nervous, and mammary systems. Neuregulin-1induced cardiac, neuronal, and mammary differentiation is based on a cellcell communication model, where the ligand neuregulin-1 is produced and secreted by one cell type, which does not express its receptors erbB3 and erbB4 and acts on neighboring cell types that do express these receptors. We proposed that neuregulin-1 affects fetal lung maturation through a similar mechanism. Immunostaining showed neuregulin-1 in fetal lung that increased in fibroblasts at the onset of surfactant synthesis. Neuregulin-1ß was found to be secreted by the fetal lung fibroblast and stimulated type II cell surfactant synthesis. Both fetal lung fibroblast-conditioned media and neuregulin-1 stimulated erbB2 receptor phosphorylation in type II cells. The effects of neuregulin-1 and of fibroblast-conditioned media on both surfactant synthesis and type II cell erbB2 phosphorylation were specifically blocked by antibody to neuregulin-1. Thus, neuregulin-1ß may control fetal lung maturation through mesenchymalepithelial interactions in a paracrine mechanism similar to that described for the developing heart, brain, and mammary systems.
Key Words: fetal lung development fibroblastpneumocyte factor fibroblast-conditioned medium erbB receptors fibroblast type II cell communication
This article has been cited by other articles:

|
 |

|
 |
 
T. D. Le Cras, T. R. Korfhagen, C. Davidson, S. Schmidt, M. Fenchel, M. Ikegami, J. A. Whitsett, and W. D. Hardie
Inhibition of PI3K by PX-866 Prevents Transforming Growth Factor-{alpha}-Induced Pulmonary Fibrosis
Am. J. Pathol.,
February 1, 2010;
176(2):
679 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C L Bose, C E L Dammann, and M M Laughon
Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate
Arch. Dis. Child. Fetal Neonatal Ed.,
November 1, 2008;
93(6):
F455 - F461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Purevdorj, K. Zscheppang, H. G. Hoymann, A. Braun, D. von Mayersbach, M.-J. Brinkhaus, A. Schmiedl, and C. E. L. Dammann
ErbB4 deletion leads to changes in lung function and structure similar to bronchopulmonary dysplasia
Am J Physiol Lung Cell Mol Physiol,
March 1, 2008;
294(3):
L516 - L522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Zscheppang, W. Liu, M. V. Volpe, H. C. Nielsen, and C. E. L. Dammann
ErbB4 regulates fetal surfactant phospholipid synthesis in primary fetal rat type II cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 2007;
293(2):
L429 - L435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. L. Dammann, N. Nassimi, W. Liu, and H. C. Nielsen
ErbB receptor regulation by dexamethasone in mouse type II epithelial cells
Eur. Respir. J.,
December 1, 2006;
28(6):
1117 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al.
Functional Genomics of Lung Disease
Am. J. Respir. Cell Mol. Biol.,
August 1, 2004;
31(2/S1):
S1 - S81.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Provost, M. Simard, and Y. Tremblay
A Link between Lung Androgen Metabolism and the Emergence of Mature Epithelial Type II Cells
Am. J. Respir. Crit. Care Med.,
August 1, 2004;
170(3):
296 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
277 - 287.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|